CLYM
Climb BioFNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Operating peers and competitors
Source-backed product markets and frozen research comparisons. Valuation comparators remain in the existing peer table.
Loading market evidence...
Research comparisons do not establish forecast usefulness or trading returns.
Compare shared product markets
Membership only; no portfolio weights or estimated losses.
+
Peers tracked
11
U.S. public peers
Grade Position
Below peers
vs peer average
CLYM vs peer average
17/100
CLYM vs. peer average (F vs. C)
Grade spread
A 2 · B 2 · C 4 · D 1 · F 2
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
VERA is the first available peer comparator.
Vera is a pathway comparator for CLYM116 because Climb's 10-K names atacicept among BAFF/APRIL competitors, but it is not a direct same-stage peer and mainly serves as an advanced benchmark for how far ahead the APRIL field already is [#10-K-2026-03-05].
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
CLYM
Climb Bio
VERA
Vera Therapeutics
Grade
F
C
Momentum
16
21
Value
41
41
Sentiment
45
75
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Mixed
Grade position vs VERA
CLYM / VERA
Grade Position
Below peers
CLYM vs. peer average (F vs. C)
17/100
Momentum
16
VERAValue
41
CLYMSentiment
45
VERARotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs CLYM
VERA is the first peer returned for this comparison set.